STOCK TITAN

EARLY WARNING NEWS RELEASE - DR. ALBERT D. FRIESEN'S HOLDINGS IN MEDICURE INC.

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

The press release details the filing of an Early Warning Report by Dr. Albert D. Friesen regarding his increased ownership of Medicure Inc. shares. As of September 22, 2022, Dr. Friesen acquired an additional 14,100 Common Shares at $1.00 each, raising his total to 2,554,027 shares, or 24.91% of the company. This acquisition surpasses the 2% ownership threshold that triggers reporting obligations. Dr. Friesen also holds options for an additional 146,500 shares, increasing his total to 25.97% on a partially diluted basis. The report will be filed according to applicable securities laws.

Positive
  • Dr. Friesen's ownership of Medicure Inc. shares increased to 24.91%, showing strong confidence in the company.
  • The acquisition of shares may signal potential future buying, indicating positive market sentiment.
Negative
  • None.

WINNIPEG, MB, Sept. 26, 2022 /PRNewswire/ - This release is being issued in connection with the filing of an early warning report (the "Early Warning Report") pursuant to the requirements of National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues regarding the change in the ownership and control of common shares (the "Common Shares") of Medicure Inc. (the "Issuer") by Dr. Albert D. Friesen ("Dr. Friesen"). The Issuer's head office address and Dr. Friesen's business address is 2-1250 Waverley Street, Winnipeg, Manitoba, Canada, R3T 6C6.

Since December 31, 2019, Dr. Friesen has acquired Common Shares exceeding 2% of the outstanding Common Shares of the Issuer. This 2% reporting threshold was reached on September 22, 2022 with the acquisition of 14,100 Common Shares representing approximately 0.14% of the Issuer's outstanding Common Shares (the "Acquisition").  The Common Shares were purchased at a price of $1.00 per share through the facilities of the TSX Venture Exchange.

Immediately prior to the Acquisition, Dr. Friesen had ownership of, directly and indirectly, or exercised control or direction over, 2,539,927 Common Shares (representing 24.78% of the issued and outstanding Common Shares of the Issuer).

Immediately after completion of the Acquisition, Dr. Friesen has ownership of, directly and indirectly, or exercises control or direction over, 2,554,027 Common Shares (representing 24.91% of the issued and outstanding Common Shares of the Issuer).

Dr. Friesen also holds options entitling him to purchase an aggregate of 146,500 Common Shares upon exercise of the options, resulting in Dr. Friesen having ownership of, directly and indirectly, or exercising control or direction over 2,700,527 Common Shares (representing 25.97% of the issued and outstanding Common Shares of the Issuer on a partially diluted basis).

Dr. Friesen holds securities of the Issuer for investment purposes.  He may, from time to time and depending on market and other conditions, acquire additional Common Shares and/or other equity, debt or other securities or instruments of the Issuer in the open market or otherwise, and reserves the right to dispose of any or all of the securities in the open market or otherwise at any time and from time to time, and to engage in similar transactions with respect to the securities, the whole depending on market conditions, the business and prospects of the Issuer and other relevant factors.

The Early Warning Report will be filed by Dr. Friesen in accordance with applicable securities laws. To obtain a copy of the Early Warning Report, please contact Medicure Inc. at 204-487-7412, 2-1250 Waverley Street, Winnipeg, Manitoba, Canada, R3T 6C6, Email: info@medicure.com.

Cision View original content:https://www.prnewswire.com/news-releases/early-warning-news-release--dr-albert-d-friesens-holdings-in-medicure-inc-301632523.html

SOURCE Dr. Albert D. Friesen

FAQ

What is the recent change in Dr. Albert D. Friesen's holdings in Medicure Inc. (MCUJF)?

Dr. Albert D. Friesen increased his holdings to 2,554,027 Common Shares, representing 24.91% of Medicure Inc. (MCUJF) as of September 22, 2022.

How many additional shares did Dr. Friesen acquire in Medicure Inc. (MCUJF)?

Dr. Friesen acquired an additional 14,100 Common Shares of Medicure Inc. (MCUJF) at a price of $1.00 per share.

What percentage of Medicure Inc. (MCUJF) does Dr. Friesen own after his latest acquisition?

After his latest acquisition, Dr. Friesen owns 24.91% of the outstanding Common Shares of Medicure Inc. (MCUJF).

Does Dr. Friesen hold any options for additional shares in Medicure Inc. (MCUJF)?

Yes, Dr. Friesen holds options to purchase an aggregate of 146,500 Common Shares, increasing his total ownership to 25.97% on a partially diluted basis.

MEDICURE INC

OTC:MCUJF

MCUJF Rankings

MCUJF Latest News

MCUJF Stock Data

6.54M
7.65M
26.68%
23.1%
0.17%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Winnipeg